Germany· DE-A57-f7d8ba1acda84832

Lorazepam Macure

A lorazepam product containing lorazepam, registered in Germany by Macure Pharma Aps. The same ATC class is registered in 16 of our 19 countries.

ATC N05BA06

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lorazepamAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lorazepam is registered in 16 of 19 countries.

Countries holding a registration under ATC N05BA06 (lorazepam), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
8 of them publish a price we can compare per daily dose

Search lorazepam products by name

Lorazepam · ATC N05BA06

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lorazepam costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.084 in France to $0.81 in Switzerland — a ×9.6 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lorazepam · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.81
ES Spain$0.16
FR France$0.084

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)

Active substance: Lorazepam
Manufacturer: Macure Pharma Aps
Country: Germany (DE)
ATC code: N05BA06
ATC class: Lorazepam
Defined daily dose: 2.5 mg, O
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

413 interactions on record for lorazepam.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lorazepam against other medicines How interaction checks work

Lorazepam · interactions on record

413 records

4 severe
70 moderate
22 minor
266 info

Most severe, free to view

MorphineN02AA01severe
MorphinN07BC09severe
HydrocodoneR05DA03severe
CodeineR05DA04severe

51 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lorazepam in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lorazepam products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Lorazepam Macure, Temesta
Belgium · Lambutrix, Lorazepam Ab
Bulgaria · Лоразепам Tzf, Лорапам
Cyprus · Lorans, Lorivan
Czechia · Temelor
Denmark · Lorazepam Macure, Lorazepam Orion
Estonia · Lorans, Temelor
Spain · Lorazepam Aurovitas, Lorazepam Cinfa
Finland · Lorazepam Macure, Lorazepam Orion
France · Lorazepam Arrow, Lorazepam Viatris
United Kingdom (Northern Ireland) · Lorazepam, Lorazepam Alissa Healthcare Research
Greece · Akivass, Dorm
Croatia · Lorsilan, Temelor
Hungary · Loranxil, Lorazepam Orion
Ireland · Ativan, Lorazepam Aspire Pharma (Malta)
Italy · Control, Lorans
Lithuania · Dalixen, Lirezid
Luxembourg · Lambutrix, Lorazepam Eg
Latvia · Lorafen, Lorazepam Macure
Malta · Ativan, Lorivan
Netherlands · Lambutrix, Lorazepam Accord Healthcare
Norway · Lorazepam Macure, Rativor
Poland · Lorabex, Lorafen
Portugal · Ansilor, Lorazepam Aristo
Romania · Anxiar, Temelor
Sweden · Lorazepam Macure, Lorazepam Orion
Slovenia · Lorazepam Macure, Lorsilan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c462672c-e5cf-4327-874f-de1d88bc6c3b
GET /v1/drugs/c462672c-e5cf-4327-874f-de1d88bc6c3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intramuscular Use ,Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Lorazepam",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about lorazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console